This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wielenga, V. J. M. Articles by Pals, S. T. Search for Related Content PubMed PubMed Citation Articles by Wielenga, V. J. M. Articles by Pals, S. T.

(American Journal of Pathology. 2000;157:1563-1573.)
© 2000 American Society for Investigative Pathology

Regular Articles

Expression of c-Met and Heparan-Sulfate Proteoglycan Forms of CD44 in Colorectal Cancer

Vera J. M. Wielenga^*, Robbert van der Voort^*, Taher E. I. Taher^*, Lia Smit^*, Esther A. Beuling^*, Cees van Krimpen, Marcel Spaargaren^* and Steven T. Pals^*

From the Department of Pathology,^*
Academic Medical Center, University of Amsterdam, Amsterdam; and the Department of Pathology,
Reinier de Graaf Hospital, Delft, The Netherlands

In colorectal cancer patients, prognosis is not determined by the primary tumor but by the formation of distant metastases. Molecules that have been implicated in the metastatic process are the proto-oncogene product c-Met and CD44 glycoproteins. Recently, we obtained evidence for functional collaboration between these two molecules: CD44 isoforms decorated with heparan sulfate chains (CD44-HS) can bind the c-Met ligand, the growth and motility factor hepatocyte growth factor/scatter factor (HGF/SF). This interaction strongly promotes signaling through the receptor tyrosine kinase c-Met. In the present study, we explored the expression of CD44-HS, c-Met, and HGF/SF in the normal human colon mucosa, and in colorectal adenomas and carcinomas, as well as their interaction in colorectal cancer cell lines. Compared to the normal colon, CD44v3 isoforms, which contain a site for HS attachment, and c-Met, were both overexpressed on the neoplastic epithelium of colorectal adenomas and on most carcinomas. Likewise, HGF/SF was expressed at increased levels in tumor tissue. On all tested colorectal cancer cell lines CD44v3 and c-Met were co-expressed. As was shown by immunoprecipitation and Western blotting, CD44 on these cells lines was decorated with HS. Interaction with HS moieties on colorectal carcinoma (HT29) cells promoted HGF/SF-induced activation of c-Met and of the Ras-MAP kinase pathway. Interestingly, survival analysis showed that CD44-HS expression predicts unfavorable prognosis in patients with invasive colorectal carcinomas. Taken together, our findings indicate that CD44-HS, c-Met, and HGF/SF are simultaneously overexpressed in colorectal cancer and that HS moieties promote c-Met signaling in colon carcinoma cells. These observations suggest that collaboration between CD44-HS and the c-Met signaling pathway may play an important role in colorectal tumorigenesis.

This article has been cited by other articles:

				A. E. Moore, A. Greenhough, H. R. Roberts, D. J. Hicks, H. A. Patsos, A. C. Williams, and C. Paraskeva HGF/Met signalling promotes PGE2 biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells Carcinogenesis, October 1, 2009; 30(10): 1796 - 1804. [Abstract] [Full Text] [PDF]

				N. Cheng, A. Chytil, Y. Shyr, A. Joly, and H. L. Moses Transforming Growth Factor-{beta} Signaling-Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion Mol. Cancer Res., October 1, 2008; 6(10): 1521 - 1533. [Abstract] [Full Text] [PDF]

				R. Singh, S. Subramanian, J. M. Rhodes, and B. J. Campbell Peanut lectin stimulates proliferation of colon cancer cells by interaction with glycosylated CD44v6 isoforms and consequential activation of c-Met and MAPK: functional implications for disease-associated glycosylation changes Glycobiology, July 1, 2006; 16(7): 594 - 601. [Abstract] [Full Text] [PDF]

				H. Takeuchi, J. Kim, A. Fujimoto, N. Umetani, T. Mori, A. Bilchik, R. Turner, A. Tran, C. Kuo, and D. S.B. Hoon X-Linked Inhibitor of Apoptosis Protein Expression Level in Colorectal Cancer Is Regulated by Hepatocyte Growth Factor/C-Met Pathway via Akt Signaling Clin. Cancer Res., November 1, 2005; 11(21): 7621 - 7628. [Abstract] [Full Text] [PDF]

				M. Hecht, M. Papoutsi, H. D. Tran, J. Wilting, and L. Schweigerer Hepatocyte Growth Factor/c-Met Signaling Promotes the Progression of Experimental Human Neuroblastomas Cancer Res., September 1, 2004; 64(17): 6109 - 6118. [Abstract] [Full Text] [PDF]

				J. A. Recio and G. Merlino Hepatocyte Growth Factor/Scatter Factor Induces Feedback Up-Regulation of CD44v6 in Melanoma Cells through Egr-1 Cancer Res., April 1, 2003; 63(7): 1576 - 1582. [Abstract] [Full Text] [PDF]

				H. Takeuchi, A. Bilchik, S. Saha, R. Turner, D. Wiese, M. Tanaka, C. Kuo, H.-J. Wang, and D. S. B. Hoon c-MET Expression Level in Primary Colon Cancer: A Predictor of Tumor Invasion and Lymph Node Metastases Clin. Cancer Res., April 1, 2003; 9(4): 1480 - 1488. [Abstract] [Full Text] [PDF]

				E. M. J. Boon, R. van der Neut, M. van de Wetering, H. Clevers, and S. T. Pals Wnt Signaling Regulates Expression of the Receptor Tyrosine Kinase Met in Colorectal Cancer Cancer Res., September 15, 2002; 62(18): 5126 - 5128. [Abstract] [Full Text] [PDF]

				T. Horikawa, T.-S. Sheen, H. Takeshita, H. Sato, M. Furukawa, and T. Yoshizaki Induction of c-Met Proto-Oncogene by Epstein-Barr Virus Latent Membrane Protein-1 and the Correlation with Cervical Lymph Node Metastasis of Nasopharyngeal Carcinoma Am. J. Pathol., July 1, 2001; 159(1): 27 - 33. [Abstract] [Full Text] [PDF]